Athanasios J. Archimandritis
About
In The Last Decade
Athanasios J. Archimandritis
131 papers receiving 3.2k citations
Peers
Comparison fields: 5 of 112
- Epidemiology 1.9k
- Hepatology 1.3k
- Surgery 884
- Pulmonary and Respiratory Medicine 344
- Immunology 301
Countries citing papers authored by Athanasios J. Archimandritis
This map shows the geographic impact of Athanasios J. Archimandritis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Athanasios J. Archimandritis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Athanasios J. Archimandritis more than expected).
Fields of papers citing papers by Athanasios J. Archimandritis
This network shows the impact of papers produced by Athanasios J. Archimandritis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Athanasios J. Archimandritis. The network helps show where Athanasios J. Archimandritis may publish in the future.
Co-authorship network of co-authors of Athanasios J. Archimandritis
This figure shows the co-authorship network connecting the top 25 collaborators of Athanasios J. Archimandritis. A scholar is included among the top collaborators of Athanasios J. Archimandritis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Athanasios J. Archimandritis. Athanasios J. Archimandritis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | Autoimmune hepatitis, 2 years after successful peg-interferon-alpha 2b plus ribavirin treatment in a patient with chronic hepatitis C | 1 |
| 2 | 9 | |
| 3 | 78 | |
| 4 | 10 | |
| 5 | 13 | |
| 6 | 16 | |
| 7 | 38 | |
| 8 | Serum apoptotic caspase activity as a marker of severity in chronic hepatitis C virus infection | 1 |
| 9 | 100 | |
| 10 | 68 | |
| 11 | 4 | |
| 12 | 2 | |
| 13 | 36 | |
| 14 | 2 | |
| 15 | 5 | |
| 16 | 5 | |
| 17 | 77 | |
| 18 | 38 | |
| 19 | 1 | |
| 20 | 7 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.